bone builder
bone builder, licence 80025338: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Genuine Health Inc.
- NPN or DIN-HM
- 80025338
- Status
- Active licence
- Licence date
- 16 May 2011
- Revision date
- 15 January 2014
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Sélénium: up to 500 µg a day according to the dosing instructions published by Health Canada (25 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Calcium: up to 1,000 mg a day according to the dosing instructions published by Health Canada (25 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 800 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine D: up to 100 µg a day according to the dosing instructions published by Health Canada (25 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Sélénium: up to 500 µg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (255 µg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine B12 Source : Cyanocobalamine | 2.0 mcg | 50 µg |
| Equisetum arvense Source : Equisetum arvense Potency : 602.0 mcg Silica | 8.6 mg | Not calculated |
| Equisetum arvense Source : Parties aériennes Potency : 602.0 mcg Silica | 8.6 mg | Not calculated |
| Sélénium Source : Saccharomyces cerevisiae | 20.0 mcg | 500 µg |
| Calcium Source : Calcium formate | 40.0 mg | 1,000,000 µg |
| Folate Source : Acide folique | 80.0 mcg | Not calculated |
| Vitamine D Source : Cholécalciférol Potency : 160.0 UI | 4.0 mcg | 100 µg |
Non-medicinal ingredients
Stéarate de magnésium, Eau, Gélatine, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 5.0 Capsule | 5.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Promotes bone formation, and enhances calcium absorption and retention. Calcium intake, when combined with sufficient vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis. Helps in the development and maintenance of bones and teeth and with the absorption and use of calcium and phosphorus.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80025338
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2014. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.